Clinical Study of Abhaya And Ashwagandha Granules In the Management Of Generalized Anxiety Disorder

Randomized Comparative Clinical Study of Abhaya And Ashwagandha Granules In the Management Of Generalized Anxiety Disorder W. S. R Vishada

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052886

Enrollment

Registered

2023-05-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex between the age of 20â??60 years, fulfilling DSM V diagnostic criteria for Generalized Anxiety Disorder (GAD) will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Patients taking medication for stress disorder, 2.Patients with symptoms of Unmad(co-morbid psychiatric disorders); on psychotropic drugs four weeks prior to study; substance abuse like alcohol etc.; significant depression (BDI >17); 3.Other medical complications like uncontrolled hypertension, diabetes mellitus; •Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
â?¢Change in Hamiltonâ??s Anxiety Rating Scale.Timepoint: 28 Days	—

Secondary

Measure	Time frame
â?¢Change in Pittsburgh Sleep Quality Index (PSQI) â?¢Change in WHO Quality of Life- BREF (WHOQOL-BREF) â?¢Change in Clinical Global Improvement scale (CGI) â?¢Change in Serum Cortisol level Timepoint: 28 Days	—

Countries

India

Contacts

Public ContactDr Monika Singh

NATIONAL INSTITUTE OF AYURVEDA

armurthy_2005@yahoo.com9314513659

Outcome results